BioSpace News Archive

Policy

AHF Commends Biden for Drug Price Controls

AIDS Healthcare Foundation commended President Joseph Biden on his administration’s efforts to control drug pricing by compelling pharmaceutical companies choosing to participate in Medicare to engage in drug price negotiations.

August 29, 2023
·
1 min read
Deals

Inotiv Announces the Sale of its Israeli Businesses to Harlan Holdings Ltd.

Inotiv, Inc., a leading contract research organization specializing in nonclinical and analytical drug discovery and development services and research models and related products and services, announced the completion of the sale of its businesses in Israel.

August 29, 2023
·
3 min read
Epigenic Therapeutics Announces $32 Million in Series A Funding to Bring Breakthrough Epigenome Medicine to Clinical Development

Epigenic Therapeutics today announced that it has raised $32 million in Series A round of financing co-led by Qiming Venture Partners and OrbiMed, with participation from existing investor Morningside Venture Capital.

August 29, 2023
·
5 min read
BioVaxys and The Ohio State University Extend Research Collaboration

BioVaxys Technology Corp. (CSE: BIOV) (OTCQB: BVAXF) (5LB: FRA) (“BioVaxys” or “the Company”), is pleased to announce that it has further extended its research collaboration with The Ohio State University (“The Ohio State”) for SARS-CoV-2, SARS-CoV-1, and pan-sarbecovirus vaccine research.

August 29, 2023
·
6 min read
Akeso Announced 2023 Interim Results: First Profit, Growing Sales of PD-1/CTLA-4 Bispecific Antibody and Priority Review of PD-1/VEGF

Akeso released its 2023 interim performance: the Company achieved financial profitability for the first time in the first half of 2023, reaping success in new drug development, commercialization and globalization.

August 29, 2023
·
5 min read
Bio NC

BioSkryb Genomics Partners with Research Instruments Pte Ltd to Bring Industry Leading Single-Cell Technologies to Singapore and Southeast Asia

BioSkryb Genomics announced a partnership with Research Instruments Pte Ltd, a premier distributor for genomic and life science research products in Southeast Asia, to distribute BioSkryb’s ResolveDNA® and ResolveOME™ single cell amplification tools throughout Singapore and Southeast Asia.

August 29, 2023
·
4 min read
Business

LSLPharma Group Announces Its Second Quarter 2023 Results

Groupe LSL Pharma Inc. announced its financial results for the second quarter ended June 30, 2023.

August 29, 2023
·
9 min read
Business

Fosun Pharma Announces 2023 Interim Results: Continues to Promote Innovation Transformation and Optimizes Product Structure

Shanghai Fosun Pharmaceutical Co., Ltd.* announced its 2023 Interim Results for the first half of 2023.

August 29, 2023
·
13 min read
Drug Development

InxMed Receives Approval to Initiate Phase I Clinical Trial in China for OMTX705, a First-in-Class FAP-Targeting ADC

InxMed announced the first-in-class ADC OMTX705 has obtained the IND approval from China National Medical Products Administration recently.

August 29, 2023
·
2 min read
Mindray Introduces Innovative Upgrades to A Series Anaesthesia Systems for Enhanced Patient Safety and Efficiency

Mindray, a global leader in providing advanced medical device solutions, has unveiled upgrades to its A7 and A5 anaesthesia systems under the A Series Anaesthesia.

August 29, 2023
·
2 min read